Verdict: Mixed

Key finding: The drop is a valuation downgrade plus sector beta, not a business problem. Q2 2026 revenue grew +32% with a 44% operating margin and EPS up from $0.42 to $0.62. But HOOD is the most expensive name in its group (~18x sales vs ~13x for IBKR), and the stock is now -33% from its 52-week closing high, with Q3 earnings on Oct 27.

Scorecard

Ticker Rev last Q ($M) Rev YoY last Q Rev YoY prior Q Gross margin (last Q, trend) Op margin EPS last Q vs yr ago P/S Mkt cap 1-mo price %
HOOD 1,308 +32.3% +15.1% 82.0% (up from 80.6%) 43.9% $0.62 vs $0.42 ~18.1x $89.2B -11.6%
IBKR 2,953 +19.6% +16.9% 95.2% (down from 96.1%) 86.4% $0.69 vs $0.51 ~13.2x $146.1B -7.3%
SCHW 8,518 +25.0% +9.8% 83.0% (down from 88.8%) 43.1% $1.54 vs $1.08 ~5.3x $160.6B -9.8%
COIN 1,220 -18.5% -30.5% 84.4% (up from 69.7%) -6.0% -$1.36 vs $5.14 ~7.3x $45.9B -9.7%

Quarters ending June 30, 2026. 1-month = Sep 14 to Oct 14 close.

HOOD is the growth leader of the group (revenue +32.3%, accelerating from +15.1%) but also the most expensive (~18x sales). IBKR is the quality leader (86% operating margin). The whole group fell 7-12% in a month, so most of the move is sector-wide; HOOD fell the most, in line with its higher beta.

Move

Catalyst

Sector

Risks

Judgement

Mixed. The business is accelerating (revenue growth doubled from +15% to +32% in one quarter, margins near 44%), so the drop is not about fundamentals. But the downgrade has a point: HOOD trades at the richest multiple in its group and is a high-beta name in a market that is de-risking. The -8.5% day looks like an overreaction to one valuation call, while the broader slide from $124.72 fits the sector. Earnings on Oct 27 are the next real test.

Sources